FCGR3A and diffuse large B-cell lymphoma: However, a recent meta-analysis study by Ghesquières et al. showed no such correlation between the FCGR3A polymorphism and the overall survival of DLBCL patients using two independent cohort studies (n = 1134, America and Europe study locations) [39].